Maze Therapeutics (MAZE) Amortizatization of Intangibles (2025 - 2026)

Maze Therapeutics (MAZE) reported Amortizatization of Intangibles of $2000.0 for Q1 2026, down 99.12% sequentially from $227000.0 in Q4 2025.

Maze Therapeutics (MAZE) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Maze Therapeutics (MAZE) has 2 years of Amortizatization of Intangibles data on file, last reported at $2000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	3.22 Mn
10	Maze Therapeutics	1.49 Bn	1.49 Bn	18.21 Mn	2,000.00

Download Data